Dysregulation of Mgat5 has previously been reported to promote cancer progression in various tumor types (66–68), and studies in PDAC have suggested that Mgat5 glycans interfere with the formation of the immunological synapse between T cells and cancer cells (69). This evidence concerns the gene MGAT5 and cancer.